BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA
Clinical trials for BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise against aggressive childhood cancer
Disease control OngoingThis study tests whether adding a drug called vinorelbine to standard chemotherapy can better control high-risk rhabdomyosarcoma, a rare and aggressive muscle cancer in children and young adults. About 118 participants will receive either the standard treatment or the new combina…
Matched conditions: BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 17, 2026 00:27 UTC
-
Can adding temsirolimus boost chemo for kids and young adults with muscle cancer?
Disease control OngoingThis study tests whether adding the drug temsirolimus to standard chemotherapy helps people with intermediate-risk rhabdomyosarcoma (a type of muscle cancer) live longer without the cancer growing or coming back. About 325 participants up to age 40 are randomly assigned to receiv…
Matched conditions: BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC